Dosage and administration
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Coleus forskohlii 2X
Vaccinium myrtillus 2X
Euphrasia officinalis 3X
Gelsemium sempervirens 3X
Spigelia anthelmia 3X, 6X
Hydrastis canadensis 5X
Aconitum napellus 6X
Belladonna 6X
Eye 6X, 12X, 30X
Bryonia 12X
Phosphorus 12X
Professional Formulas
PO Box 2034 Lake Oswego, OR 97035
For the temporary relief of occasional eye pain, blurred vision, or distorted vision.*
*Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Severe or persistent symptoms may be a sign of a serious condition. Consult a doctor promptly if symptoms are accompanied by severe eye pain with nausea, or sudden vision disturbance or loss. Keep out of the reach of children. In case of overdose, get medical help or contact a poison control center right away. If pregnant or breastfeeding, ask a healthcare professional before use.
Keep out of the reach of children.
If pregnant or breastfeeding, ask a healthcare professional before use.
Place drops under tongue 30 minutes before/after meals. Adults and children 12 years and over: Take 10 drops up to 3 times per day. Consult a physician for use in children under 12 years of age.
Tamper resistant. If seal is broken, do not use. After opening, close container tightly and store at room temperature away from heat.
20% ethanol, purified water.
Est 1985
Professional Formulas
Complementary Health
Glaucoma Drops
Homeopathic Remedy
2 FL. OZ. (59 mL)
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63083-2074-2 | 2026-01-09 | C162847 | 48780-1 | 1030e365-37c8-111a-e063-dadaa90a10e2 | C74 |
| 63083-2074-2 | 2026-01-09 | C162847 | 48780-1 | 1030e365-37c8-111a-e063-dadaa90a10e2 | C74 |
| 63083-2074-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-37c8-111a-e063-dadaa90a10e2 | C74 |
| 63083-2074-2 | 2024-01-30 | C162847 | 48780-1 | 1030e365-37c8-111a-e063-dadaa90a10e2 | C74 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63083-2074-2 | Glaucoma Drops2074 | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63083-2074 | 63083-2074-2 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| PLECTRANTHUS BARBATUS ROOT OIL | 5NXR7DJ9WO | ACTIB |
| BILBERRY | 9P2U39H18W | ACTIB |
| EUPHRASIA STRICTA | C9642I91WL | ACTIB |
| GELSEMIUM SEMPERVIRENS ROOT | 639KR60Q1Q | ACTIB |
| SPIGELIA ANTHELMIA WHOLE | WYT05213GE | ACTIB |
| GOLDENSEAL | ZW3Z11D0JV | ACTIB |
| ACONITUM NAPELLUS WHOLE | U0NQ8555JD | ACTIB |
| AMARYLLIS BELLADONNA WHOLE | 11B89M58UN | ACTIB |
| BOS TAURUS EYE | VTW461N43P | ACTIB |
| BRYONIA ALBA ROOT | T7J046YI2B | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| ALCOHOL | 3K9958V90M | IACT |
| WATER | 059QF0KO0R | IACT |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 1 | 2019-08-15 | full-release | 2026-06-01 02:16:20 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glaucoma Drops 2074 | GLAUCOMA DROPS | Professional Complementary Health Formulas | 7cf2052e-15f8-4b04-ae18-1847da8f4236 | 2026-01-08 | Warnings | 63083-2074-2 63083-2074 63083207402 617f1878-a655-425b-a81f-a979be629a44 7cf2052e-15f8-4b04-ae18-1847da8f4236 |
Adverse event summaries are temporarily unavailable. Other product information remains available.